Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
37.73 USD | -4.12% | -7.99% | -17.08% |
May. 07 | Rhythm Pharmaceuticals' Q1 Net Loss Widens as Revenue Increases; Shares Fall Pre-Bell | MT |
May. 07 | Transcript : Rhythm Pharmaceuticals, Inc., Q1 2024 Earnings Call, May 07, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-17.08% | 2.4B | |
+2.03% | 106B | |
+8.21% | 23.47B | |
-14.04% | 21.9B | |
-5.94% | 18.77B | |
-37.26% | 17.85B | |
-6.60% | 16.78B | |
+8.64% | 14.41B | |
+40.91% | 12.86B | |
+321.95% | 8.78B |
- Stock Market
- Equities
- RYTM Stock
- News Rhythm Pharmaceuticals, Inc.
- Rhythm Pharmaceuticals Q3 Loss Widens, Beats Wall Street Forecast, Revenue Rises; Shares Up Pre-Bell